Characterizing Associations of QTc Interval with Nocturnal Glycemic Control in Children with Type 1 Diabetes

Verena Gotta1,2, Sara Bachmann3, Marc Pfister1

  • 1Pediatric Pharmacology and Pharmacometrics, University of Basel Children's Hospital, Basel, Switzerland.

Insights

Children with type 1 diabetes (T1D) experience mild QT prolongation during nocturnal hypoglycemia. This study quantified the association and identified factors influencing QTc variability, highlighting potential cardiac risks.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacometrics

Background:

  • Nocturnal hypoglycemia in children with type 1 diabetes (T1D) is associated with a mild QT prolongation (Bazett's corrected QT interval, QTcB) of approximately 7 milliseconds compared to euglycemia.
  • Understanding the quantitative relationship between glucose levels and QTc variability is crucial for assessing cardiac risks in this pediatric population.

Purpose of the Study:

  • To quantitatively analyze the association between QT prolongation and nocturnal hypoglycemia in children with T1D.
  • To identify and quantify other sources of QTc variability, including circadian variations, age, and sex.

Main Methods:

  • Prospective observational study involving 25 children with T1D, with continuous glucose and electrocardiogram monitoring over 5 nights.
  • Mixed-effect modeling was employed to compare different QTc correction methods (QTcB vs. QTcI) and to develop covariate models.
  • Analysis included univariable and adjusted models to investigate glucose-QTc relationships and explore factors modifying QTc sensitivity.

Main Results:

  • The individual heart-rate corrected QT interval (QTcI) model reduced inter-individual variability compared to QTcB.
  • An adjusted covariate model further reduced variability, accounting for significant QTc shortening in adolescent boys, circadian variations, and a linear glucose-QTc relationship.
  • A delayed association between glucose levels and QTc was observed, with the longest QTc interval around 3:00 AM, influenced by the extent and duration of hypoglycemia.

Conclusions:

  • A clinically mild but quantifiable association between QTc prolongation and nocturnal hypoglycemia was confirmed in children with T1D.
  • Factors such as hemoglobin A1c (HbA1c), T1D duration, and time spent in hypoglycemia influence QTc sensitivity.
  • Further research is warranted to determine if these findings contribute to an increased risk of cardiac arrhythmias associated with hypoglycemia in children with T1D.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
213
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
238
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
603
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
305